AUPH(Aurinia Pharmaceuticals Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $45.60M | $134.03M | $175.51M | $235.13M | $283.06M |
| 毛利润 | $44.51M | $128.37M | $161.37M | $206.88M | $250.39M |
| 营业利润 | −$180.74M | −$111.47M | −$91.69M | −$4.69M | $104.91M |
| 净利润 | −$180.97M | −$108.18M | −$78.02M | $5.75M | $287.20M |
| 经营现金流 | −$157.69M | −$79.53M | −$33.46M | $44.39M | $135.66M |
| 自由现金流 | — | — | — | — | — |
| 摊薄每股收益 | $-1.40 | $-0.76 | $-0.54 | $0.04 | $2.07 |